ask why
Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

The papers that matter: 18 May to 24 May 2026

The 10 most important of the 132 papers published that week and summarised on Y, ranked by what verified readers said would change practice, then by strength of design and size. Secondary analyses come last.
Public health and primary care · PLoS Med · 2026-05-22

Systematic review and meta-analysis of 102 prevalence surveys (4,658,310 adults, 33 LMICs): pulmonary TB prevalence was higher in men, pooled male-to-female ratio 2.02 (95% CrI 1.71–2.34) for bacteriologically confirmed TB; time trend uncertain but consistent with widening gap.

Meta-analysisn = 4,658,310
Swartwood et al. Differences in tuberculosis prevalence by sex in low- and middle-income countries over 1993-2025: A systematic review and meta-analysis
Women's health · Acta Obstet Gynecol Scand · 2026-05-20

Systematic review of 6 studies: in 2 RCTs (1634 women) universal mid-trimester cervical length screening plus vaginal progesterone for short cervix did not significantly reduce preterm birth versus no screening; 4 cohort studies showed associated reductions. Very low certainty.

Meta-analysisn = 427,369
Zethelius et al. Can universal cervical length screening with vaginal progesterone for a short cervix reduce preterm birth? A systematic review and meta-analyses
Vascular surgery · J Vasc Surg · 2026-05-22

Systematic review of 10 observational studies (5794 participants): elevated Lp(a) was associated with PAD prevalence (pooled OR 1.81). After lower-extremity revascularisation, in only 2 cohorts, it was linked to major adverse limb events (OR 5.09) and major amputation (OR 2.62).

Meta-analysisn = 5,794
Mwipatayi et al. A systematic review and meta-analysis of elevated lipoprotein(a) and adverse limb outcomes in peripheral artery disease after revascularization
Urology · Prostate Cancer Prostatic Dis · 2026-05-18

Meta-analysis of 5 RCTs (4536 patients) with biochemical recurrence after radical prostatectomy: adding short-term hormonal therapy to salvage radiotherapy improved metastasis-free survival (HR 0.82) and PFS (HR 0.58), but neither duration improved overall survival.

Meta-analysisn = 4,536
Migliaccio et al. Salvage radiotherapy with or without hormonal therapy for biochemical recurrence after radical prostatectomy: A systematic review and meta-analysis

Previous weekNext weekAll weeks

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.